ACTR-07. LIMITED IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE BEYOND 12 CYCLES IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAS

OBJECTIVE: Radiotherapy combined with concomitant/adjuvant temozolomide (TMZ) is the standard treatment for patients with newly diagnosed glioblastomas (GBM). However, the optimal cycles of adjuvant TMZ remains controversial. Until December 2013 we treated patients with GBM with maximum 24 cycles of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Ohno, Makoto, Miyakita, Yasuji, Takahashi, Masamichi, Matsushita, Yuko, Kitagawa, Yosuke, Yamauchi, Takahiro, Kitamura, Natsuko, Ichimura, Koichi, Narita, Yoshitaka
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692386/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky